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ABSTRACT
Objective: Determine change in serum prostate-specific antigen (PSA) and International Index of Erectile Function (IIEF-
5) following transurethral resection of the prostate (TURP). Material & Method: Eighteen men with age range of 50 – 69 
years, were divided in two groups, group I 50-59 years (mean 56,5) and group II 60-69 years (mean 67,2). Both groups 
underwent measurement of serum PSA and IIEF-5 pre-operative, and repeated at 30, 60, and 90 days after TURP. Results: 
Level of serum PSA after TURP is decreased in most patients after 30, 60, and 90 days (72%, 72% and 78%). Mean value of 
PSA pre-operatively is 5,3 ± 3,3 ng/ml. After TURP, serum PSA level was 3,5 ± 3,0 ng/ml (30 days); 2,9 ± 2,9 ng/ml (60 days) 
and 1,8 ± 1,3ng/ml (90 days). Pre-operative PSA level was significantly decreased in Group I during the 60 and 90 days post 
TURP, while in Group II pre-operative PSA level was significantly decreased only in 90 days of observation. Overall there is 
no significant difference in PSA levels in both groups (p > 0,05). The decrease of PSA per gram resected in 30, 60, and 90 
days were 0,10 ng/ml; 0,16 ng/ml and 0,24 ng/ml consecutively. There is no change in normal IIEF-5 score. Decrease of the 
IIEF-5 score in group I was measured at 30 days, but the score increased after 60 and 90 days. Meanwhile Group II showed 
decrease of IIEF-5 score. Pre-operative IIEF-5 score compared to the 30 days post TURP was significantly different but not 
significantly different compared with to score at 60 and 90 days. In Group I IIEF-5 score was significantly higher compared 
to Group II (p < 0,05). Prostatitis was found in 8 patients, but there is no difference in serum PSA level decrease between 
patients with or without prostatitis. Conclusion: There was significant decrease in serum PSA after TURP in BPH patients 
with LUTS at every measurement at 30, 60, and 90 days. PSA level after TURP depends on various factors, including pre-
operative PSA, pre-operative prostate volume and prostate volume resected. Incidence of erectile dysfunction post TURP 
was low. 
Keywords: Prostate-specific antigen, benign prostatic hyperplasia, transurethral resection of the prostate, erectile 
dysfunction.
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ABSTRAK
Tujuan Penelitian: Mengkaji bagaimana sifat dan perubahan PSA, IIEF-5 setelah TURP pada BPH-LUTS. Bahan & 
Cara: Pada 18 pria umur antara 50-69 tahun, terbagi 2 kelompok 50-59 dan 60-69 tahun, rerata umur masing-masing 
kelompok 56,5 tahun dan 67,2 tahun. Pemeriksaan pre operasi meliputi PSA serum dan IIEF-5, volume prostat yang diukur 
dengan TRUS, PSA, dan IIEF-5 dievaluasi sebelum operasi dan 30, 60, 90 hari. Hasil Penelitian: PSA cenderung menurun 
setelah TURP pada seluruh evaluasi 30, 60, 90 hari. Rerata PSA sebesar 72,2% (530 hari), 72,2% (60 hari) dan 77,8% 
setelah 90 hari. Kadar rerata PSA pre op 5,3 ± 3,3 ng/ml dan setelah TURP bervariasi 3,5 ± 3,0 ng/ml (30 hari), 2,9 ± 2,9 
ng/ml (60 hari), 1,8 ± 1,3 ng/ml (90 hari). Terdapat perbedaan signifikan PSA pre op dengan PSA 60, 90 hari kelompok umur 
50-59 tahun dan terdapat perbedaan signifikan PSA pre op dengan 90 hari pada kelompok umur 60-69 tahun. Antara 
kelompok umur tidak terdapat perbedaan yang signifikan dengan nilai p > 0,05. Besarnya penurunan PSA serum dalam 
pergram volume reseksi prostat didapat 0,10 ng/ml/gram pada 30 hari, 0,16 ng/ml/gram (60 hari) dan 0,24 ng/ml/gram 
dalam 90 hari. Tidak terdapat pasien dengan skor IIEF-5 normal berubah menjadi disfungsi ereksi. Penurunan IIEF-5 skor 
lebih besar  kelompok 50-59 tahun pada hari ke 30 namun peningkatan terjadi pada hari ke 60 dan 90 sedangkan kelompok 
60-69 tahun tetap terjadi penurunan. Terdapat perbedaan signifikan IIEF-5 pre op dengan hari ke-30, sedangkan dengan 
hari ke 60, 90 hari tidak menunjukkan perbedaan yang signifikan. IIEF-5 pre op dengan hari ke 60 dan 90 Antara kelompok 
umur 50-59 dan 60-69 tahun terdapat perbedaan signifikan p < 0,05. Didapatkan temuan penelitian BPH dengan 
prostatitis n = 8 namun tidak ada perbedaan penurunan PSA serum pre op dengan 30, 60, 90 hari dibandingkan dengan 
BPH tanpa prostatitis. Simpulan: Kadar PSA menurun drastis pada pasien yang menjalani TURP. Titik nadir PSA terjadi 
pada 90 hari. Volume reseksi prostat sebagai parameter estimasi rerata penurunan PSA serum. Rendahnya komplikasi 
disfungsi ereksi, sehingga TURP merupakan prosedur yang masih aman. Penemuan prostatitis tidak mempengaruhi nilai 
variabel dan tidak ada perbedaan penurunan PSA. 
Kata kunci: Prostate-specific antigen, benign prostatic hyperplasia, transurethral resection of prostate, disfungsi ereksi.
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INTRODUCTION
Prostate Specific Antigen (PSA) is a tumor 
marker with a role in diagnosing and evaluating 
diseases of the prostate and its use continues to 
increase further. The nature of change in PSA after 
TURP is very important, because of its limitations as 
a tumor marker of prostate cancer whose values 
overlap with BPH. Failure of PSA to reach nadir after 
TURP indicates the existence of residual cancer or 
inflammation. Prostate-inflammatory effects on 
post-TURP serum PSA value are not fully under-
stood. Although many studies suspect this inflamma-
tion contributes to increased PSA level, there 
remains controversy over its mechanism, such as 
presence of histopathological changes that induces 
prostate acini marker entry into systemic 
1,2circulation.
In a previous study by Fonseca et al (2008) there 
was no age-related decline in PSA level after TURP 
1in all measurements.  Whereas a study by Chung et al 
(2006) found strong correlation between age and 
increasing serum PSA, in which the increase was 
335,9% per decade of life.  Further studies are needed 
on change of serum PSA to analyze whether age 
contributes to different decrease in serum PSA after 
TURP.
Frequent TURP in Soetomo Hospital has 
encouraged the authors to carry out further 
investigation. Previous retrospective studies 
revealed 123 BPH patients who underwent TURP 
from January to December 2005. Of 123 BPH 
patients, 70 were associated with urinary retention 
and the remaining 53 were BPH patients with Lower 
4Urinary Tract Symptom (LUTS).
Prostate Specific Antigen (PSA) is a tumor 
marker derived from prostatic epithelial cells used in 
the diagnosis and evaluation for patients with 
prostate diseases. Although many factors affect PSA 
decline after TURP, its value ranges from 72% less 
from the initial value, even though the volume of the 
resected prostate is small. This is because the 
resected tissue is largely from the transitional zone, 
1which is the highest PSA producer.  Those issues 
should be reexamined in light of the differences in 
races and populations as well as examination 
method, which may provide varied outcome data 
about PSA.
Complications resulting from TURP include 
erectile dysfunction (ED), necessitates simultaneous 
analysis in this study. Evaluation was performed 
using International Index of Erectile Function-5 
(IIEF-5) score as a subjective parameter of erectile 
function assessment. Previous research has shown 
incidence of ED after TURP between 4-40%. 
Difference in incidence of post-TURP ED is caused 
by differences in methods used to assess ED due to 
differences in time of post-TURP follow-up, and one 
of the most important factors of diagnosis and 
5 evaluation of ED is erectile function. Incidence of 
post-TURP erectile dysfunction varies widely, 
ranging from 0-40%, while, according to Taher 
5,6 (2004) 14%, and Paulakis (2006) 12%. The IIEF-5 
scoring system has not been examined for validity 
and reliability in BPH patients without urinary 
retention in Indonesia, particularly in Surabaya.
OBJECTIVE
To compare the change in serum PSA levels and 
IIEF-5 score before and after TURP in BPH patients 
without urinary retention.
MATERIAL & METHOD
This study was an observational analytic study 
conducted from January to August 2010, to study 
differences in serum PSA levels, IIEF-5 score, 
differences in serum PSA changes by age group and 
PSA change per volume of prostate resected (g) in 
BPH patients without urinary retention, as well as 
testing the validity and reliability of the IIEF-5 
scoring system questionnaire in Indonesian.
Overall sample size that fulfilling the inclusion 
criteria was 20 individuals who were divided into 2 
observations groups by age, from 50-59 years and 
60-69 years. There was 1 drop out in each group 
refusal to continue follow up (PSA examination and 
complete IIEF-5 until days 60 and 90) because 
feeling better. Each age group of 50-59 years and 60-
69 years comprised 9 individuals. Inclusion criteria 
in this study were (1) male patient diagnosed with 
BPH without urinary retention undergoing TURP, (2) 
age from 50 to 69 years, (3) PSA value ≤ 10 ng/ml.
Data were analyzed descriptively and 
analytically. Prior to conducting the hypothesis tests, 
test on data distribution and homogeneity was 
performed. The difference between PSA, IIEF-5 on 
days 30, 60, and 90 post-TURP, and the volume of 
prostate resected were tested using Anova or t test 
that were previously tested for normality using 
Kolmogorov Smirnov. Data were analyzed with 
commercial software. Results of normality tests on 
all data showed normal distribution (p > 0,05), so that 
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the statistical test used was parametric statistical 
tests, the paired t test and independent t test.
RESULTS
The assessment result of two independent 
samples t test on the volume of prostate resected and 
prostate volume showed no difference (Table 1). So 
it can be said resection of prostate volume and 
prostate volume between the two groups was 
homogeneous and it can be seen that the two 
variables were not confounding factors.
Table 2 shows the changes in the decrease of pre-
surgical PSA in all groups after TURP in days 30, 60, 
and 90 of observation. On day 90 post-TURP serum 
PSA decreased below 4 ng/ml.
Changes in serum PSA showed improvement 
and reduction of the difference in pre-surgical PSA 
to day 30, 60, and 90 (Table 3). This change was 
dominated by patients whose serum PSA decreased, 
despite some of the patients still having elevated 
PSA. Persistent elevated PSA may be caused by 
inflammation resulting from the TURP procedure. 
Increased PSA was found in 5 patients from both 
groups on day 30 and 60, and 4 patients on day 90.
In age group 50-59 years, statistical testing 
showed significant differences in pre-surgical PSA 
Table 1.Description of research data.
 
Table 2. Description of pre-surgical PSA data.
with PSA on day 60 and 90 (Table 4), and no 
significant difference between pre-surgical PSA with 
PSA on day 30. Calculation in age group of 60-69 
year showed significant differences in pre-surgical 
PSA with PSA on day 90, while pre-surgical PSA 
with PSA on day 30 and 60 did not show significant 
differences. 
Table 5 showed no significant difference in pre-
surgical PSA with PSA on day 30, 60, and 90 (p > 
0,05).
PSA decrease on day 30 per gram tissue resected 
(table 6) is smallest, 0,1023 ng/ml. PSA decrease on 
day 60 was 0,1638 ng/ml per gram tissue resected, 
whereas the largest decrease per tissue resected was 
observed on day 90 (0,2495 ng/ml). Comparison of 
serum PSA decrease pergram volume resected in this 
study could be used as an estimate.
Table 7 showed significant differences in pre-
operative IIEF-5 with the IIEF-5 on day 30, while 
pre-operative IIEF-5 with IIEF-5 on day 60 and 90 
did not show significant differences.
Table 8 showed no significant difference in pre-
operative IIEF-5 decrease with IIEF-5 on day 30 (p > 
0,05), but there were significant differences in the 
decrease of pre-operative IIEF-5 with IIEF-5 score 
on day 60 and 90 (p < 0,05).
Results calculated with two independent samples 
Note*= Significant at 0,05
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50 - 59 years  60 - 69 years
Observed aspects  
Mean N SD Mean N SD
Independent 
samples t test
Age  56,5  9  1,5  67,2  9  2,1  0,001*  
Prostate volume  30,40  9  12,572  36,18  9  13,916  0,369  
Resected tissue weight  13,14  9  9,579  17,51  9  10,426  0,368  
PSA Pre-operative  5,1956  9  3,322  5,4878  9  3,551  0,859  
PSA day 30  2,8444  9  2,484  4,2000  9  3,462  0,354  
PSA day 60  2,1444  9  1,563  3,8333  9  3,867  0,242  
PSA day 90  1,7333  9  1,580  1,9667  9  1,125  0,723  
IIEF Pre-operative  13,3333  9  8,573  9,0000  9  5,958  0,231  
IIEF day 30  8,6667  9  8,485  4,6667  9  4,555  0,231  
IIEF day 60  16,5556  9  9,748  6,1111  9  4,729  0,014*  
IIEF day 90 15 7778 9 8 643 5 0000 9 4 387 0 004*
PSA Pre-operative  PSA day 30  PSA day 60  PSA day 90 
Mean  5,3417  3 5222 2 9889 1 8500
Std. Deviation 3 33938 3 00520 2 99016 1 33560
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Table 3. Description of the difference and percentage of increase or decrease in PSA.
Table 4. PSA paired t test.
Table 5. PSA independent t test.
Note* = significant at alpha 0,05
Table 6. Decrease of serum PSA per gram prostate tissue resected.
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Statistics PSA decrease/tissue weight on day 30
PSA decrease/tissue 
weight on day 60
PSA decrease/tissue 
weight on day 90
Mean 0 1023 0 1638 0,2495 
Std. Deviation 0 46003 0 41905 0,46459
Minimum -1 27 - 0 68 -0 67
Maximum 0 78 0 94 1 30
 
Groups Homogeneity t Sig. 
PSA Pre-operative – PSA day 30 Homogeneous 0,508 0,618 
PSA Pre-operative – PSA day 60 Homogeneous 0,771 0,452 
PSA Pre operative PSA day 90 Homogeneous 0 031 0 976
Age 50  59 years Age 60  69 yearsVariables
t Sig t Sig
PSA Pre-operative – PSA day 30 2 100 0 069 0 728 0 487 
PSA Pre-operative – PSA day 60 2,722 0,026* 1,162 0,279 
PSA Pre-operative – PSA day 90 2 915 0 019* 2 319 0 049*
Difference of  PSA 
pre and day 30 Categories
Difference of  PSA 
pre and day 60
 
Categories Difference of  PSA pre and day 90
 
Categories
-3,2
 
Increased
 
-1,7
 
Increased
 
0,6
 
Decreased
 -1,1
 
Increased
 
-1,1
 
Increased
 
-3,4
 
Increased
 1,2
 
Decreased
 
4,7
 
Decreased
 
6,5
 
Decreased
 3,46
 
Decreased
 
5,26
 
Decreased
 
5,26
 
Decreased
 2,4
 
Decreased
 
1,8
 
Decreased
 
3,4
 
Decreased
 3,4
 
Decreased
 
2,7
 
Decreased
 
4
 
Decreased
 1,1
 
Decreased
 
1,1
 
Decreased
 
0,9
 
Decreased
 7
 
Decreased
 
7,9
 
Decreased
 
8,1
 
Decreased
 6,9
 
Decreased
 
6,8
 
Decreased
 
5,8
 
Decreased
 8,7
 
Decreased
 
8,8
 
Decreased
 
9,7
 
Decreased
 2,79
 
Decreased
 
2,89
 
Decreased
 
1,89
 
Decreased
 -5,5
 
Increased
 
-4,6
 
Increased
 
-1,6
 
Increased
 0,8
 
Decreased
 
1,5
 
Decreased
 
-1,9
 
Increased
 5,1
 
Decreased
 
-4
 
Increased
 
7,6
 
Decreased
 -1,4
 
Increased
 
-0,5
 
Increased
 
-1
 
Increased
 2,8
 
Decreased
 
3
 
Decreased
 
5,5
 
Decreased
 5,8
 
Decreased
 
5,6
 
Decreased
 
8,8
 
Decreased
 7 5 Increased 2 2 Decreased 2 7 Decreased
% Increased 27,8%  27,8%  22,2% 
% Decreased 72,2% 72,2% 77,8%
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Table 7. Paired t test of IIEF-5 score.
Table 8. Independent t test IIEF-5.
 
Table 9. Research data and t test results in patients with BPH-LUTS without prostatitis and BPH-LUTS with 
prostatitis.
revealed that serum PSA concentrations increased 
transiently during the first several days post-TURP 
1and decreases gradually thereafter.
Total PSA decrease from pre-surgery until day 90 
was 3,5211 ng/ml, consistent with Chung et al (2006) 
who found a strong correlation between age and 
serum PSA, in which serum PSA increased 35,9% 
3per decade of life.  These initial PSA values may be 
influenced by many factors. One example is race, the 
value in Afro-American men is higher than that in 
thCaucasian men without prostate cancer. The 90  day 
of observation was observed as the lowest point of 
PSA in this study. This was possible by re-
epithelialization and completion of wound healing in 
8the first 12 weeks.
Table 2 shows the trend of PSA decline after 30, 
60, and 90 days compared to pre-surgical PSA. This 
is consistent with findings of Marks (1996) that in 
partial prostatectomy such as TURP for BPH related 
symptoms, PSA also decreased, although not 
reaching the zero. After adenoma removal in BPH, 
PSA drops drastically and proportional to the volume 
9of resected tissue.  After TURP, number of prostate 
epithelial cells as PSA producer will be reduced, thus 
Note* = significant at alpha 0,05
Note* = significant at alpha 0,05
t test (table 9) showed no difference in pre-surgical 
PSA decrease with that on days 30, 60, and 90 
between BPH-LUTS without prostatitis compared to 
BPH-LUTS with prostatitis.
DISCUSSION
Samples included in this study were BPH-LUTS 
patients with age more than 50 years. This is in 
accordance with McConnell (2005) that the prostate 
enlarges gradually after the age of 50 years or more 
and after age 70, about 8 out of 10 males may have an 
7enlarged prostate.
The decrease from initial total PSA between pre-
surgery up to day 90 was as much as 3,4623 ng/ml. 
This decrease was possible because resection of 
PSA-producing epithelial cells cause reduced PSA 
production. Gradual decrease in serum PSA on day 
30 may be attributed to inflammation, which is 
followed by tissue healing. Serum PSA on day 60 it 
continues to reduce toward nadir, with further 
reduction up to day 90. This is regarded as the lowest 
point compared to baseline in age group 50-59 years. 
Similarly, the findings of Fonseca et al (2008) 
Indonesian Journal of Urology, Vol. 19, No. 1, January 2012: 42 - 48
Age 50 – 59 years Age 60 – 69 yearsVariables  
t Sig t Sig
IIEF Pre-operative and IIEF day 30 2,514 0,036* 2,871 0,021*
IIEF Pre-operative and IIEF day 60 -2,029 0,077 2,080 0,071
IIEF Pre-operative and IIEF day 90 -1 777 0 113 2 248 0 055
Groups Homogeneity t Sig. 
IIEF Pre-operative and IIEF day 30 Homogeneous 0,139 0,891 
IIEF Pre-operative and IIEF day 60 Homogeneous 2,897 0,011* 
IIEF Pre-operative and IIEF day 90 Homogeneous 2,865 0,011* 
BPH without prostatitis BPH with prostatitis Observed aspects 
Mean N SD Mean N SD 
t test sig. 
Difference of PSA pre and day 30 2,7560 10 3,58928 0,6487 8 5,13805 0,321
Difference of PSA pre and day 60 2,1160 10 3,95338 2,6487 8 3,84216 0,777
Difference of PSA pre and day 90 3,1960 10 4,14881 3,8613 8 3,97668 0,735
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causing decrease of PSA.
Regarding pre-operative PSA difference on days 
30, 60, and 90 (Table 3), serum PSA decreased 
respectively by 72,2%, 72%, 77,8% compared to 
baseline PSA, but some still showed an increase by 
27,8%, 27,8%, and 22,2%, respectively. So it can be 
inferred that the greatest difference in PSA decline of 
the entire observation time occurred on day 90. The 
results of this study was greater than that obtained by 
Aus G et al (1996) who measured the level of PSA 
before and 3 months after TURP in 190 patients with 
BPH and an the mean of PSA decrease was 70% 
10post-TURP.  It can be stated that the greatest decline 
in PSA this study occurred in 3 months, indicating 
that complete wound healing has occurred, that the 
inflammatory factors have minimal influence on 
PSA levels, but there was also PSA increase on day 
90. According to Brosman (2009) this demonstrates 
that in general PSA level is continually detected and 
still increases, possibly indicating the presence of 
2cancer cells.  The presence of these cells can served 
as a predictor in this study because these cells are 
generally located in peripheral zone therefore not 
resected during TURP, where the peripheral zone 
represents 80% of the sites of origin of prostate 
cancer. However, this study did not obtain the results 
of histopathologic examination with prostate Ca.
Results assessed with paired t test (Table 4) on 
the PSA indicated there were significant differences 
in the age group 50-59 years of pre-surgical PSA on 
day 60 (p = 0,026) and 90 (p = 0,019), whereas pre-
surgical PSA on day to 30 showed no significant 
difference (p = 0,069). The assessment of age group 
60-69 years showed a significant difference only in 
pre-surgical PSA on day 90 (p = 0,049), whereas PSA 
on day 30 and 60 did not show significant differences 
(p > 0,05), respectively p = 0,487 and p = 0,279. This 
is due to the occurrence of post-TURP inflammatory 
process in which prostate epithelial cells as PSA 
producers are still releasing much PSA that are 
leaking through basal membrane into vascular 
system, so that high serum PSA can still be found on 
2day in both groups.  On day 60, serum PSA in group 
of 50-59 years became significant compared to pre-
operative PSA. This indicates that younger age 
experiences greater PSA decline compared to pre-
operation. This may be because age group of 50-59 
years has faster surgical wound healing, so prostate 
epithelial cells do not present anymore. Whereas, 
observation on day 90 showed that both groups had 
significant values. In 90 days prostate re-
epithelialization has completed, so that PSA leaks 
through basal membrane into vascular system is 
reduced and the value of PSA can be regarded as 
stable at this time. Unfortunately, there was no 
comparison of longer observation time after 90 days 
to assess the length of time of PSA stabilization. This 
is different from the study by Fonseca et al (2008), in 
which they found that age was not associated with 
post-TURP decrease in PSA levels in all 
1measurement times.
Independent t test in PSA (table 5) showed no 
significant difference in pre-surgical PSA decline vs 
that in 30, 60, and 90 days (p > 0,05) and both groups 
were regarded as homogeneous. A previous study by 
Fonseca et al (2008) found that age was not associated 
with post-TURP decrease in serum PSA levels in all 
1measurement times.
Tissue weight in each PSA decrease or increase in 
PSA on day 30 (table 6) is the smallest comparative 
figures of 0,1023 ng/ml, and the comparative figures 
in on day 60 is 0,1638 ng/ml, whereas on day 90 the 
comparative figures is the greatest, 0,2495 ng/ml. It 
can be concluded that mean decrease in serum PSA 
per gram obtained in this study was taken from the 
smallest value of the PSA value on day 30 of 0,10 
ng/ml. Transitional zone is the largest source of PSA 
production, and if this zone is resected, the serum 
PSA levels would certainly decrease. Thus, prostate 
resection volume can be measured by PSA that results 
from partial adenomectomy. The results obtained in 
this study differed from those of Lloyd et al (1996), 
who found that per gram PSA decrease in resected 
11tissue was 0,09 ng/ml.  The results of this study were 
similar to those of Marks et al (1996) who found that 
the mean decrease of serum PSA in per gram resected 
9tissue was 0,11 ng/ml.  The difference in the results of 
those studies may result from different populations 
and methods of PSA measurement, whether it was 
enzymatic or by radioimmunoassay.
Paired t test results of IIEF-5 (table 7) showed 
significant differences of IIEF-5 in age group 50-59 
years between pre-surgical score and that on day 30 (p 
= 0,036), while pre-operative IIEF-5 and IIEF-5 on 
days 60 and 90 did not show significant differences, 
which were p = 0,077 and p = 0,113, respectively. 
Similarly, in age group 60-69 years, the results of 
assessment also indicated that significant differences 
was only in IIEF-5 days 30 (p = 0,021), while IIEF-5 
day 60 and 90 did not show significant differences, 
respectively p = 0,071 and p = 0,055. This showed a 
tendency of decreasing IIEF-5 score on day 30 
because the patients have not had complete recovery 
with the persistence of fear, confidence on the degree 
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of erection had not recovered either, while clinically 
the patient still complained pain during intercourse 
and micturition. IIEF-5 evaluation on day 30 
observation was also seemed too early to do. Some 
patients may experience temporary post-TURP ED 
and the return of erection ability may occur in 2-3 
5months post-TURP.
Results of independent test of IIEF-5 (Table 8) 
shows that the results of assessment revealed no 
significant difference in pre-operative IIEF-5 
decrease and IIEF on day 30 (p > 0,05). However, 
there was significant difference in pre-operative IIEF 
decrease and IIEF on days 60 and 90 (p < 0,05). This 
difference suggests that sexual erectile function in 
age group 60-69 years was decreasing compared to 
that in group of 50-59 years. According Roehrborn 
(2002), in BPH the role of testosterone as a male sex 
hormone would generally decrease due to decreased 
number of Leydig cells and estrogen levels in male 
plasma also increased due to peripheral 
aromatization, so this may trigger the decline of male 
12sexual function.
Assessment in Table 9 shows that the decrease of 
PSA in BPH with prostatitis group is larger than that 
of BPH patients without prostatitis. The decrease of 
PSA in BPH group with highest prostatitis occurred 
between pre-surgical vs day 30 with a mean decrease 
in PSA of 0,6487 ± 5,13805 ng/ml. Results assessed 
with two independent samples t test indicated no 
significant difference in pre-surgical PSA decline vs 
those on days 30, 60, and 90. It is possible because 
TURP in BPH with prostatitis may reduce sources of 
chronic inflammatory lesions of glandular epithelial 
cells. Unlike the study by Lawrenrschuk (2007), 
serum PSA in BPH-LUTS with prostatitis not only 
highly increased serum PSA but also returned to 
initial level, depending on the recovery of infection 
13and may require time ranging from 6 to 8 weeks.
CONCLUSION
There are differences in post-TURP serum PSA 
in patients with BPH-LUTS in each evaluation on 
days 30, 60, and 90, and there was decrease in serum 
PSA in day 90 of observation. Post-TURP PSA 
depends on many factors; pre-operative PSA, pre-
operative prostate volume, and the volume of 
resection of the prostate. The estimated decrease in 
post-TURP serum PSA can be assessed based on the 
parameters of the size of prostate resection volume. 
The low complication of erectile dysfunction is due 
to TURP.
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